Source: Medical Xpress, 6 November 2026
Medical Xpress reports: "A particular signaling protein in the brain could be a therapeutic target for neurological disorders arising from the deletion of the autism-linked gene MEF2C, University of Illinois Urbana-Champaign researchers found..."
Read the full story at Medical Xpress
This is a short report on news published elsewhere. The Australian Autism ADHD Foundation is not responsible for external content, and including it here is not an endorsement. For advice about your own situation, please speak with a qualified health professional.
